查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1678457

美国干眼症治疗市场：市场规模、份额、趋势分析（按类型、药物、剂型、销售管道、分销管道）、细分市场预测（2025-2030 年）

U.S. Dry Eye Syndrome Treatment Market Size, Share & Trends Analysis Report By Type, By Drugs, By Product, By Dosage Form, By Sales Channel, By Distribution Channel, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10个工作天内

价格

美国干眼症治疗市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，美国干眼症治疗市场规模预计到2030年将达到34.7亿美元，预测期内的复合年增长率为6.0%。

美国干眼症（DED）市场的成长很大程度上是由其高盛行率所推动的。到 2024 年，大约 6.8% 的成年人口将被诊断出患有这种疾病，随着老龄化的增长，患病率会显着增加，尤其是在女性中。

庞大的患者群体凸显了对有效治疗方案的迫切需求，这为满足该群体需求的主要企业创造了一个蓬勃发展的市场。人口老化，特别是65岁以上的人口老化是导致DED发病率上升的主要原因。这种人口结构的变化导致治疗需求增加，製药公司和医疗保健提供者也调整了其策略。

2023 年和 2024 年，随着人们对使用数位设备时间增加导致的 DED 认识的不断提高，需求将进一步激增。治疗方案的创新，包括处方药和非处方药（OTC），正在提高诊断率。到 2025 年，Reproxalap、IC 265 和 Acoltremon 等较新的治疗药物有望增强缓解效果并推动未来的市场扩张。

美国干眼症治疗市场：概述

  • 大约2000万美国中DED的发生率不断上升，凸显了迫切的治疗需求和公司的市场机会。
  • 从类型来看，蒸发过强型干眼症将占据主导地位，占2024年总销售额的82.5%。
  • 按药物划分，Cequa 预计在预测期内以最快的复合年增长率增长 27.0%。
  • 从产品角度来看，Cyclosporine在 2024 年凭藉其在治疗干眼症、显着增加泪液分泌和抑制发炎方面所展现的临床疗效引领市场。
  • 眼药水，尤其是人工泪液，可以滋润眼睛并模仿自然泪液，从而快速缓解干眼症状。
  • 根据处方笺，预计成药在预测期内的复合年增长率最快，为 6.5%。
  • 零售药局将主导市场，其中线上药局在预测期内的复合年增长率最快，为 6.6%。
  • 2024 年 8 月，OCuSOFT 在美国推出了处方笺强度抗组织胺 Retaine Allergy，加强了其专注于干眼症治​​疗和缓解过敏的产品线。

目录

第一章 分析方法及范围

第 2 章执行摘要

第 3 章美国干眼症治疗市场：驱动因素、趋势与范围

  • 市场联动展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 商业环境分析
    • 产业分析：波特五力分析
    • PESTEL 分析

第 4 章美国干眼症治疗市场：按类型分類的业务分析

  • 按类型分類的市场占有率（2024 年和 2030 年）
  • 按类型分類的仪表板
  • 按类型分類的市场规模预测及趋势分析（2018-2030）
  • 蒸发
  • 水样泪液缺乏型

第 5 章美国干眼症治疗市场：药物业务分析

  • 按药物类型分類的市场占有率（2024 年和 2030 年）
  • 药物仪錶板
  • 依药物类型分類的市场规模预测及趋势分析（2018-2030年）
  • 汐多拉
  • 雷斯塔西斯
  • 塞夸
  • 蒂亚
  • 阿塞维斯
  • 其他的

第六章美国干眼症治疗市场：按产品分類的业务分析

  • 按产品市场占有率（2024 年和 2030 年）
  • 产品仪表板
  • 依产品分類的市场规模预测及趋势分析（2018-2030）
  • 人工泪液
  • Cyclosporine
  • 局部固醇
  • 泪点塞
  • 口服欧米茄补充剂
  • 其他的

第 7 章美国干眼症治疗市场：按剂型分類的业务分析

  • 按剂型分類的市场占有率（2024 年及 2030 年）
  • 配方仪表板
  • 按剂型分類的市场规模预测及趋势分析（2018-2030年）
  • 眼药水/溶液
  • 软膏和凝胶
  • 胶囊和锭剂
  • 其他的

第 8 章美国干眼症治疗市场：按销售管道的业务分析

  • 按销售管道分類的市场占有率（2024 年和 2030 年）
  • 销售管道仪表板
  • 依销售管道分類的市场规模预测及趋势分析（2018-2030 年）
  • 处方药
  • 场外交易（OTC）

第 9 章美国干眼症治疗市场：按分销管道分類的业务分析

  • 按分销管道分類的市场占有率（2024 年和 2030 年）
  • 分销通路仪表板
  • 按分销管道分類的市场规模预测及趋势分析（2018-2030 年）
  • 分销通路市场占有率，2024 年和 2030 年
  • 分销通路细分仪表板
  • 2018 年至 2030 年按分销管道分類的市场规模、预测和趋势分析
  • 零售药局
  • 医院药房
  • 网路药局

第十章 竞争格局

  • 参与者概述
  • 企业市场分析
  • 公司分类
  • 战略地图
  • 公司简介/上市公司
    • Novartis AG
    • AbbVie Inc.
    • Sun Pharmaceutical Industries Ltd.
    • Janssen Pharmaceutica（Pty.）Ltd.
    • OASIS Medical, Inc.
    • Viatris Inc.
    • Bausch Health Companies Inc.
    • Santen Pharmaceutical Co., Ltd.
Product Code: GVR-4-68040-514-4

U.S. Dry Eye Syndrome Treatment Market Growth & Trends:

The U.S. dry eye syndrome treatment market size is anticipated to reach USD 3.47 billion by 2030 and is anticipated to expand at a CAGR of 6.0% during the forecast period, according to a new report by Grand View Research, Inc. Market growth in the U.S. for dry eye disease (DED) has been significantly influenced by its high prevalence. By 2024, this condition has shown notable age-related increases, particularly among women, with around 6.8% of the adult population diagnosed.

The substantial patient base has highlighted the urgent need for effective treatment options, leading to a burgeoning market for companies catering to this demographic's needs. The aging population, particularly those aged 65 and older, has significantly contributed to the rising incidence of DED. This demographic shift has created increased demand for treatment as pharmaceutical companies and healthcare providers have adapted their strategies.

In 2023 and 2024, heightened awareness of DED, linked to increased screen time from digital devices, has further surged demand. Innovations in treatment options, including prescription medications and over-the-counter (OTC) products, have improved diagnosis rates. By 2025, new therapies such as Reproxalap, IC 265, and Acoltremon are anticipated to enhance relief and drive future market expansion.

U.S. Dry Eye Syndrome Treatment Market Report Highlights:

  • The growing prevalence of DED in approximately 20 million Americans highlights urgent treatment needs and market opportunities for companies.
  • Based on type, evaporative dry eye syndrome dominated the type segment, accounting for 82.5% of the total revenue share in 2024.
  • Based on drugs, Cequa is projected to grow at the fastest CAGR of 27.0% over the forecast period.
  • Based on product, cyclosporine led the market in 2024, demonstrating clinical efficacy in treating dry eye syndrome, significantly increasing tear production and reducing inflammation.
  • Eye drops, especially artificial tears, offer rapid relief from dry eye symptoms by lubricating the eyes and mimicking natural tears, thus dominating the dosage form segment in 2024.
  • Based on prescription, OTC drugs are expected to register the fastest CAGR of 6.5% over the forecast period.
  • Retail pharmacies dominated the market, with online pharmacies exhibiting the fastest CAGR of 6.6% over the forecast period.
  • In August 2024, OCuSOFT launched Retaine Allergy prescription-strength antihistamine drops in the U.S., enhancing its product line focused on dry eye solutions and allergy relief.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Drugs
    • 1.2.3. Product
    • 1.2.4. Dosage Form
    • 1.2.5. Sales Channel
    • 1.2.6. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Dry Eye Syndrome Treatment Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. U.S. Dry Eye Syndrome Treatment Market: Type Business Analysis

  • 4.1. Type Market Share, 2024 & 2030
  • 4.2. Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Evaporative
    • 4.4.1. Evaporative Market, 2018 - 2030 (USD Million)
  • 4.5. Aqueous Deficient
    • 4.5.1. Aqueous Deficient Market, 2018 - 2030 (USD Million)

Chapter 5. U.S. Dry Eye Syndrome Treatment Market: Drugs Business Analysis

  • 5.1. Drugs Market Share, 2024 & 2030
  • 5.2. Drugs Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Drugs, 2018 to 2030 (USD Million)
  • 5.4. Xiidra
    • 5.4.1. Xiidra Market, 2018 - 2030 (USD Million)
  • 5.5. Restasis
    • 5.5.1. Restasis Market, 2018 - 2030 (USD Million)
  • 5.6. Cequa
    • 5.6.1. Cequa Market, 2018 - 2030 (USD Million)
  • 5.7. Tyrvaya
    • 5.7.1. Tyrvaya Market, 2018 - 2030 (USD Million)
  • 5.8. Eysuvis
    • 5.8.1. Eysuvis Market, 2018 - 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. U.S. Dry Eye Syndrome Treatment Market: Product Business Analysis

  • 6.1. Product Market Share, 2024 & 2030
  • 6.2. Product Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 6.4. Artificial Tears
    • 6.4.1. Artificial Tears Market, 2018 - 2030 (USD Million)
  • 6.5. Cyclosporine
    • 6.5.1. Cyclosporine Market, 2018 - 2030 (USD Million)
  • 6.6. Topical Corticosteroids
    • 6.6.1. Topical Corticosteroids Market, 2018 - 2030 (USD Million)
  • 6.7. Punctal Plugs
    • 6.7.1. Punctal Plugs Market, 2018 - 2030 (USD Million)
    • 6.7.2. Removable
      • 6.7.2.1. Removable Market, 2018 - 2030 (USD Million)
    • 6.7.3. Dissolvable
      • 6.7.3.1. Dissolvable Market, 2018 - 2030 (USD Million)
  • 6.8. Oral Omega Supplements
    • 6.8.1. Oral Omega Supplements Market, 2018 - 2030 (USD Million)
  • 6.9. Others
    • 6.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. U.S. Dry Eye Syndrome Treatment Market: Dosage Form Business Analysis

  • 7.1. Dosage Form Market Share, 2024 & 2030
  • 7.2. Dosage Form Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by Dosage Form, 2018 to 2030 (USD Million)
  • 7.4. Eye Drops / Solutions
    • 7.4.1. Eye Drops / Solutions Market, 2018 - 2030 (USD Million)
  • 7.5. Ointments and Gels
    • 7.5.1. Ointments and Gels Market, 2018 - 2030 (USD Million)
  • 7.6. Capsules & Tablets
    • 7.6.1. Capsules & Tablets Market, 2018 - 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Others Market, 2018 - 2030 (USD Million) Market, 2018 - 2030 (USD Million)

Chapter 8. U.S. Dry Eye Syndrome Treatment Market: Sales Channel Business Analysis

  • 8.1. Sales Channel Market Share, 2024 & 2030
  • 8.2. Sales Channel Segment Dashboard
  • 8.3. Market Size & Forecasts and Trend Analysis, by Sales Channel, 2018 to 2030 (USD Million)
  • 8.4. Prescription
    • 8.4.1. Prescription Market, 2018 - 2030 (USD Million)
  • 8.5. OTC
    • 8.5.1. OTC Market, 2018 - 2030 (USD Million)

Chapter 9. U.S. Dry Eye Syndrome Treatment Market: Distribution Channel Business Analysis

  • 9.1. Distribution Channel Market Share, 2024 & 2030
  • 9.2. Distribution Channel Segment Dashboard
  • 9.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
  • 9.4. Retail Pharmacies
    • 9.4.1. Retail Pharmacies Market, 2018 - 2030 (USD Million)
  • 9.5. Hospital Pharmacies
    • 9.5.1. Hospital Pharmacies Market, 2018 - 2030 (USD Million)
  • 9.6. Online Pharmacies
    • 9.6.1. Online Pharmacies Market, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Participant Overview
  • 10.2. Company Market Position Analysis
  • 10.3. Company Categorization
  • 10.4. Strategy Mapping
  • 10.5. Company Profiles/Listing
    • 10.5.1. Novartis AG
      • 10.5.1.1. Overview
      • 10.5.1.2. Financial Performance
      • 10.5.1.3. Product Benchmarking
      • 10.5.1.4. Strategic Initiatives
    • 10.5.2. AbbVie Inc.
      • 10.5.2.1. Overview
      • 10.5.2.2. Financial Performance
      • 10.5.2.3. Product Benchmarking
      • 10.5.2.4. Strategic Initiatives
    • 10.5.3. Sun Pharmaceutical Industries Ltd.
      • 10.5.3.1. Overview
      • 10.5.3.2. Financial Performance
      • 10.5.3.3. Product Benchmarking
      • 10.5.3.4. Strategic Initiatives
    • 10.5.4. Janssen Pharmaceutica (Pty.) Ltd.
      • 10.5.4.1. Overview
      • 10.5.4.2. Financial Performance
      • 10.5.4.3. Product Benchmarking
      • 10.5.4.4. Strategic Initiatives
    • 10.5.5. OASIS Medical, Inc.
      • 10.5.5.1. Overview
      • 10.5.5.2. Financial Performance
      • 10.5.5.3. Product Benchmarking
      • 10.5.5.4. Strategic Initiatives
    • 10.5.6. Viatris Inc.
      • 10.5.6.1. Overview
      • 10.5.6.2. Financial Performance
      • 10.5.6.3. Product Benchmarking
      • 10.5.6.4. Strategic Initiatives
    • 10.5.7. Bausch Health Companies Inc.
      • 10.5.7.1. Overview
      • 10.5.7.2. Financial Performance
      • 10.5.7.3. Product Benchmarking
      • 10.5.7.4. Strategic Initiatives
    • 10.5.8. Santen Pharmaceutical Co., Ltd.
      • 10.5.8.1. Overview
      • 10.5.8.2. Financial Performance
      • 10.5.8.3. Product Benchmarking
      • 10.5.8.4. Strategic Initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. U.S. dry eye syndrome treatment market, by region, 2018 - 2030 (USD Million)
  • Table 4. U.S. dry eye syndrome treatment market, by type, 2018 - 2030 (USD Million)
  • Table 5. U.S. dry eye syndrome treatment market, by drugs, 2018 - 2030 (USD Million)
  • Table 6. U.S. dry eye syndrome treatment market, by product, 2018 - 2030 (USD Million)
  • Table 7. U.S. dry eye syndrome treatment market, by dosage form, 2018 - 2030 (USD Million)
  • Table 8. U.S. dry eye syndrome treatment market, by sales channel, 2018 - 2030 (USD Million)
  • Table 9. U.S. dry eye syndrome treatment market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 U.S. dry eye syndrome treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Type and drugs outlook (USD Million)
  • Fig. 10 Product and dosage form outlook (USD Million)
  • Fig. 11 Sales channel and distribution channel outlook (USD Million)
  • Fig. 12 Competitive landscape
  • Fig. 13 U.S. dry eye syndrome treatment market dynamics
  • Fig. 14 U.S. dry eye syndrome treatment market: Porter's five forces analysis
  • Fig. 15 U.S. dry eye syndrome treatment market: PESTLE analysis
  • Fig. 16 U.S. dry eye syndrome treatment market: Type segment dashboard
  • Fig. 17 U.S. dry eye syndrome treatment market: Type market share analysis, 2024 & 2030
  • Fig. 18 U.S. dry eye syndrome treatment market: Drugs segment dashboard
  • Fig. 19 U.S. dry eye syndrome treatment market: Drugs market share analysis, 2024 & 2030
  • Fig. 20 U.S. dry eye syndrome treatment market: Product segment dashboard
  • Fig. 21 U.S. dry eye syndrome treatment market: Product market share analysis, 2024 & 2030
  • Fig. 22 U.S. dry eye syndrome treatment market: Dosage form segment dashboard
  • Fig. 23 U.S. dry eye syndrome treatment market: Dosage form market share analysis, 2024 & 2030
  • Fig. 24 U.S. dry eye syndrome treatment market: Sales channel segment dashboard
  • Fig. 25 U.S. dry eye syndrome treatment market: Sales channel market share analysis, 2024 & 2030
  • Fig. 26 U.S. dry eye syndrome treatment market: Distribution channel segment dashboard
  • Fig. 27 U.S. dry eye syndrome treatment market: Distribution channel market share analysis, 2024 & 2030
  • Fig. 28 Company categorization
  • Fig. 29 Company market position analysis
  • Fig. 30 Strategic framework